Recently, the Kailuan cohort in China showed that pre-diagnostic albumin was inversely associated with lung cancer risk (HRQ4 vs. Q1 = 0.70, 95% CI: 0.52-0.95), but the inverse association became insignificant after excluding cases diagnosed within two years of enrollment (25). The gene discussed is ALB; the disease is lung carcinoma.